Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=071acc2f-9010-41e7-af4b-a8f914b5be8c
Date 3/23/2016
Company Name Quanterix
Mailing Address 113 Hartwell Avenue Lexington, MA 02421 USA
Company Description At Quanterix, our principal focus is to improve human health by providing physicians, drug developers, and researchers with the ability to detect and analyze important biomolecules within complex biological samples at the level of single molecules. The company was founded in June 2007 by successful entrepreneurs Dr. David Walt and Dr. Nick Naclerio.
Proceeds Purposes This infusion of capital will allow Quanterix to build on the significant growth realized in the last two years. Proceeds will be used to develop desk-top instruments, expand the assay menu for protein and nucleic acid biomarkers, bolster the global channel to market and enable new, pivotal medical studies to be performed with Quanterix’ game changing technology, transforming life science research and diagnostics.
M&A Terms
Venture Investor ARCH Venture Partners
Venture Investor Cormorant Asset Management
Venture Investor Bain Capital Ventures
Venture Investor Investor
Venture Investor Hercules Technology Growth Capital